Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	146.44	154.37	282.7	448.52	42.83	422.38
Short-Term Investments	606.35	847.12	677.95	230.42	313.86	0
Cash & Cash Equivalents	752.79	1,001	960.65	678.94	356.69	422.38
Cash Growth	-24.83%	4.25%	41.49%	90.34%	-15.55%	-
Receivables	0	0.31	0.4	75	0	0
Other Current Assets	17.31	17.7	15.19	16.16	3.84	1.72
Total Current Assets	770.1	1,020	976.24	770.1	360.54	424.1
Property, Plant & Equipment	68.87	75.39	27.32	28.83	31.65	3.63
Goodwill and Intangibles	2.3	2.3	2.3	0	0	0
Other Long-Term Assets	2.71	2.58	2.58	0.9	0.88	0.88
Total Long-Term Assets	73.88	80.27	32.2	29.73	32.53	4.51
Total Assets	843.98	1,100	1,008	799.83	393.07	428.61
Accounts Payable	9.21	10.58	8.28	6.35	6.99	4.71
Deferred Revenue	0	0	0.25	0	0	0
Current Debt	4.96	4.28	1.84	1.52	1.25	0.18
Other Current Liabilities	16.09	48.86	13.95	5.76	3.75	1.98
Total Current Liabilities	30.27	63.71	24.32	13.63	11.99	6.87
Long-Term Debt	48.5	53.47	21.06	22.9	23.58	0
Other Long-Term Liabilities	13.21	32.38	65.26	0	0.16	0.55
Total Long-Term Liabilities	61.71	85.84	86.31	22.9	23.74	0.55
Total Liabilities	91.98	149.55	110.64	36.54	35.73	7.42
Total Debt	53.47	57.74	22.9	24.42	24.83	0.18
Debt Growth	-7.41%	152.15%	-6.23%	-1.65%	13850.56%	-
Retained Earnings	-1,400.58	-1,058.61	-768.1	-404.23	-189.48	-114.18
Comprehensive Income	-0.2	-10.42	-1.09	0.06	0.33	0
Shareholders' Equity	752	950.22	897.81	763.29	-180.44	-110.93
Net Cash / Debt	699.33	943.75	937.75	654.52	331.86	422.21
Net Cash / Debt Growth	-25.90%	0.64%	43.27%	97.23%	-21.40%	-
Net Cash Per Share	5.71	8.41	9.86	15.36	96.18	169.89
Working Capital	739.83	955.8	951.92	756.47	348.55	417.24
Book Value Per Share	6.13	8.47	9.44	17.91	-52.29	-44.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).